Amyloidosis, extramedullary plasmacytoma, and light chain deposition disease: impressive results of daratumumab therapy

Pol Arch Intern Med. 2021 Mar 30;131(3):297-298. doi: 10.20452/pamw.15806. Epub 2021 Feb 11.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Amyloidosis* / drug therapy
  • Antibodies, Monoclonal* / therapeutic use
  • Female
  • Humans
  • Middle Aged
  • Multiple Myeloma* / drug therapy
  • Plasmacytoma* / drug therapy

Substances

  • Antibodies, Monoclonal
  • daratumumab